Cargando…

Medications that interact with direct-acting oral anticoagulant exposure

Detalles Bibliográficos
Autores principales:	de Vries, T. A. C., de Groot, J. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2021
Materias:	Editor’s Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397805/ https://www.ncbi.nlm.nih.gov/pubmed/34409566 http://dx.doi.org/10.1007/s12471-021-01617-z

Ejemplares similares

Experience with non-vitamin K antagonists in the Netherlands: stories from both sides of the desk
por: de Vries, T. A. C., et al.
Publicado: (2019)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
por: de Winter, R. J.
Publicado: (2018)

Direct oral anticoagulant failure in stroke/transient ischaemic attack: neurologic and pharmacokinetic considerations
por: Rose, David Z, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Response to editorial comment ‘Direct oral anticoagulant failure in TIA/stroke: neurologic and pharmacokinetic considerations’
por: Huynh, Ronald, et al.
Publicado: (2020)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Anticoagulation in COVID-19
por: Bradbury, Charlotte A, et al.
Publicado: (2022)

Ablation of idiopathic ventricular arrhythmias
por: de Groot, J. R.
Publicado: (2018)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

The wearable defibrillator: a most affordable vest
por: de Groot, J. R.
Publicado: (2017)

Clinical electrophysiology in the Netherlands: where do we stand?
por: de Groot, J. R.
Publicado: (2017)

Stroke prevention in patients with atrial fibrillation and comorbidities: evidence and common sense
por: de Groot, J. R.
Publicado: (2020)

What if there is no prospective, double blind, randomised trial?
por: de Groot, J. R.
Publicado: (2019)

Novel sites for pacemaker lead implantation and different routes for their extraction
por: de Groot, J. R.
Publicado: (2022)

Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018)

Novel oral anticoagulants: the translation of ‘de Leidraad’ into daily clinical practice
por: Jaspers Focks, J., et al.
Publicado: (2014)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?
por: de Groot, J. R., et al.
Publicado: (2022)

Prescription patterns of direct oral anticoagulants and concomitant use of interacting medications in the Netherlands
por: Harskamp, R. E., et al.
Publicado: (2021)

Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
por: de Groot, Joris R.
Publicado: (2023)

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?
por: Baalman, S. W. E., et al.
Publicado: (2018)

Let’s talk about sex: (title of a song from 1991 by ‘Salt ‘n Pepa’)
por: de Vries Feyens, C. A., et al.
Publicado: (2013)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Direct oral anticoagulant use in left ventricular thrombus
por: Ali, Zafar, et al.
Publicado: (2020)

Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians
por: Peacock, W. Frank, et al.
Publicado: (2016)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Should all electrocardiography be ambulatory?
por: de Groot, Joris R., et al.
Publicado: (2023)

Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
por: Rose, Adam J., et al.
Publicado: (2021)

The use of direct acting oral anticoagulants in patients with COVID-19 infection
por: Aly, Ragia, et al.
Publicado: (2021)

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal
por: Maadarani, Ossama, et al.
Publicado: (2019)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
por: Górnicki, Tomasz, et al.
Publicado: (2023)

Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021)

Non vitamin K anticoagulation drugs will win the race
por: Van Gelder, I. C., et al.
Publicado: (2016)

Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
por: Giugliano, Robert P., et al.
Publicado: (2021)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
por: Al Rowily, Abdulrhman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_29j11juh16unjq8gnnjckjbitq